HYDRALYTE_1170x120

Medicare Part D

NACDS campaigns to make things happen

NACDS campaigns to make things happen

The National Association of Chain Drug Stores was at the top of its game during the Regional Chain Conference in Palm Beach, Fla., earlier this month. Often overshadowed by the association’s larger events, this hidden gem provides attendees with an initial look at the objectives that NACDS and its members will pursue during the course

Rite Aid rolls out Medicare Advisor tool

Rite Aid rolls out Medicare Advisor tool

CAMP HILL, Pa. — As the annual Medicare Part D election period gets underway, from now through Dec. 7, 2018, Medicare-eligible customers can visit Rite Aid pharmacies nationwide to take advantage of free resources that help them select the right prescription drug plan (PDP) or update existing coverage for 2019. Patients and caregivers can use

Survey says seniors support pharmacy related reforms

Survey says seniors support pharmacy related reforms

ALEXANDRIA, Va. — Reducing drug costs borne by seniors due to middlemen and deals in the drug supply chain are Medicare Part D reforms that most strongly curry favor among registered voters, according to a Morning Consult survey commissioned by the National Community Pharmacists Association (NCPA). Conducted in late June, the survey results indicate strong support

NACDS RxIMPACT rallies senate support for action on DIR fees

NACDS RxIMPACT rallies senate support for action on DIR fees

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) RxIMPACT grassroots advocacy program has mobilized to support a U.S. Senate initiative urging action by U.S. Secretary of Health and Human Services Secretary Alex Azar on direct and indirect remuneration (DIR) fee reform in Medicare Part D. NACDS RxIMPACT pharmacy advocates are urging Senators to

PhRMA launches Medicare ad campaign for seniors

PhRMA launches Medicare ad campaign for seniors

WASHINGTON —  Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) launched the “Let’s Talk About Medicare” advertising campaign focused on solutions to improve affordability and predictability for seniors in Medicare Part D. Similar to how the “Let’s Talk About Cost” campaign opened up a conversation about costs and prescription drug coverage, this campaign builds on

NACDS praises Congress’ call for DIR fee reform

NACDS praises Congress’ call for DIR fee reform

ARLINGTON, Va. — In the growing effort to achieve pro-patient and pro-pharmacy reforms of direct and indirect remuneration (DIR) fees in Medicare Part D, the National Association of Chain Drug Stores today hailed a letter to Health and Human Services Secretary Alex Azar signed by 50 members of the U.S. House of Representatives and led

PCMA responds to Medicare Part D ruling

PCMA responds to Medicare Part D ruling

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on the Medicare Part D final rule released this week by the Department of Health and Human Services: “Two years ago drugmakers launched a campaign to deflect blame for their high prices onto health plans and pharmacy benefit

What the budget deal means for health care

What the budget deal means for health care

WASHINGTON — Health care spending has been beefed up in some areas and reduced in others as a result of the federal budget legislation passed by Congress earlier this month. Chronic care funding was bolstered by the two-year spending plan, which was signed into law by President Trump, while some Affordable Care Act appropriations were

Pharmacies feel the DIR fee pain

Pharmacies feel the DIR fee pain

Suffice it to say, community pharmacies are getting squeezed by retroactive DIR fees. That’s what the results of a survey from the National Community Pharmacists Association said. NCPA reported Friday that, because of retroactive direct and indirect remuneration fees, 84% of independent pharmacy owners polled said they don’t know what their final reimbursement will be at

NACDS, NCPA give input on Medicare Part D changes

NACDS, NCPA give input on Medicare Part D changes

WASHINGTON — The National Association of Chain Drug Stores and the National Community Pharmacists Association have submitted comments to the Centers for Medicare & Medicaid Services (CMS) as it mulls Medicare Part D prescription drug program changes for the 2019 contract year. NACDS said Wednesday that in its comments to CMS the association expressed support for and provided added input

Patients, not PBMs, should choose pharmacy

Patients, not PBMs, should choose pharmacy

WASHINGTON — In recent testimony before the House of Representatives Energy and Commerce Subcommittee on Health, National Community Pharmacists Association (NCPA) chief executive officer B. Douglas Hoey said pharmacists can drive better health outcomes and reduce costs, but first pharmacy benefit managers’ problematic business practices must be addressed through legislative and regulatory channels. As an

NACDS: Progress made on Medicare Part D changes

NACDS: Progress made on Medicare Part D changes

ARLINGTON, Va. – The National Association of Chain Drug Stores has analyzed the Centers for Medicare & Medicaid Services’ (CMS) proposed Medicare Part D changes, and found progress on topics related to advancing e-prescribing and medication therapy management (MTM); further addressing opioid issues in a pro-patient and pro-pharmacy manner; and fostering pharmacy access. CMS’ approaches

NASP hails House action on retroactive Part D fees

NASP hails House action on retroactive Part D fees

WASHINGTON — The National Association of Specialty Pharmacy (NASP) has commended 54 members of the House of Representatives for urging federal agencies to eliminate retroactive Medicare Part D fees charged by big pharmacy benefit managers. The lawmakers sent a letter to the Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid

Controversy over DIR under Medicare Part D heats up

Controversy over DIR under Medicare Part D heats up

Direct and indirect remuneration (DIR) is one component of the complex Medicare Part D payment system. In the past several months, the issue of DIR increasingly has become a source of contention between various players in the Part D program. Pharmacies, the Centers for Medicare and Medicaid Services (CMS), and members of Congress have expressed

1 2 3